• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VYGON GMBH LEADERFLEX; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VYGON GMBH LEADERFLEX; INTRAVASCULAR CATHETER Back to Search Results
Model Number 1212.20
Device Problems Break (1069); Material Separation (1562)
Patient Problems No Information (3190); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/25/2020
Event Type  malfunction  
Manufacturer Narrative
The failed sample was not returned to vygon for evaluation but the events will be part of the complaint investigation.The results of this investigation are still pending and will be communicated to fda within 30 days of its conclusion.
 
Event Description
Midline came apart at injection cap connection site.
 
Manufacturer Narrative
This complaint could not be classified as we did not receive a sample for evaluation.Two photographs were received for review; no physical sample was returned to the manufacturer for investigation.A review of the photographs provided by the account shows that the extension line came off the ll-hub.The proximal end (estimated via photograph around 1 cm) of the extension lines looks as if the surface's structure of the tube is different to the rest of the tube.This could indicate that the tube in this area was previously in the ll-hub, it had been over molded correctly and was pulled out of the hub by applying high forces.A review of the batch history records showed no deviations.Each catheter is flow and leak tested during production.The tensile force of the catheter components is randomly checked.Incoming goods inspections and two 100% visual tests after packaging are carried out.The tensile force of extension line/ll-hub for the involved batch was between 20,1 n and 47,0 n and therefore within our specification (min.15 n).This is the very first complaint for batch 110220gh and the very first complaint regarding an extension line coming off the ll-hub on code 1212.20 within the last three years.No further corrective action initiated by quality management due to the missing sample, no root cause analysis can be made.Corrective action: no further corrective action initiated by quality management due to the missing sample.However, both vygon usa and germany will continue to monitor this issue.
 
Event Description
Midline came apart at injection cap connection site.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEADERFLEX
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
VYGON GMBH
prager ring 100
aachen 52070
GM  52070
MDR Report Key10656209
MDR Text Key210656790
Report Number2245270-2020-00088
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
PMA/PMN Number
) K141026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 10/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number1212.20
Device Catalogue Number1212.20
Device Lot Number110220GH
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/26/2020
Initial Date FDA Received10/09/2020
Supplement Dates Manufacturer Received08/26/2020
Supplement Dates FDA Received10/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-